< Back to latest news & events

Articles

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

June 2025

 

This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as highlighting the problems associated with asserting IP rights in relation to breeding programs conducted across different jurisdictions.

A US plant patent provides protection for asexually produced plants (apart from tuber propagated plants and uncultivated plants).  A plant patent owner has the right to exclude third parties from “asexually reproducing the plant, and from using, offering for sale, or selling the plant so reproduced, or any of its parts, throughout the United States, or from importing the plant so reproduced, or any parts thereof, into the United States.”  Notably, in contrast to plant variety rights, a plant patent does not provide protection against unauthorised export of the protected plant.

The case relates to the breeding of strawberries, with the patentee (Driscoll) in 2019 alleging that California Berry Cultivars (CBC) had infringed three of their US plant patents, firstly by cross-breeding the patented varieties in Spain, and then secondly by importing seed derived from the cross-breeding program into the US.

In strawberries, the male plant provides the pollen, and the female plant produces the fruit and seeds.  However, most strawberry flowers include both male and female reproductive parts, and so in a cross-breeding event, any single variety could be used as either the male or the female parent.

Driscoll’s allegation relating to infringement as a result of unauthorised importation of seed was based on the argument that their patented plants were used as female plants for crossbreeding, and therefore the seeds imported in the US were a “part” of a patented plant.  To support this allegation, they needed to provide evidence as to which variety was used as the female in each cross.  However, the CBC’s breeding plans did not specify which variety was used as the female in each cross, and there was no evidence of how each cross was performed.  The Judge found that Driscoll relied on “guesswork and speculation” regarding the parents in the cross-breeding, and had failed to meet its evidentiary burden in showing that the seed was indeed a ‘part’ of one of their protected varieties.  The Judge remarked that “the mere existence of progeny of a patented plant does not support an inference that that Defendants imported and used seeds that were grown on a Patented Plant, as opposed to the other variety in any given cross”. 

The Judge further dismissed the allegation of infringement based on cross-breeding because this activity was performed in Spain and therefore outside of the jurisdiction of Driscoll’s US plant patents.

Breeding programs often take place across multiple jurisdictions, and the protection afforded can differ between patents, plant patents, and plant variety rights.  This case again highlights the complexities in adequately protecting innovation in this sector, the challenges in obtaining evidence relating to third-party activities, and protecting the rights of breeders.


This article was written by Partner & Patent Attorney Punita Shah, and Trainee Patent Attorney Delphine Lauté-Caly.

Latest updates

Event - 5th May 2026

IP Clinic for SMEs at ETZ EnergyWorks

We’re pleased to announce a free Intellectual Property (IP) clinic taking place at ETZ EnergyWorks in Aberdeen on Wednesday 27th May, from 11.00am to 4.00pm, designed to support SMEs in …

Event details

Managing IP EMEA Awards

HGF celebrates five wins at the Managing IP EMEA Awards, recognising its strength as a leading European IP firm HGF is delighted to announce that the firm has won five …

Read article

WIPR Leaders 2026

We are proud to announce that five of our attorneys have been recognised in the 2026 WIPR Leaders directory, a prestigious guide to the world’s leading intellectual property practitioners. Pieter …

Read article

Celebrating Our New Partners

We are delighted to announce that, with effect from 1 May, HGF has promoted five colleagues to Partner. This important milestone recognises not only their individual achievements and leadership, but …

Read article
Event - 11th - 12th May 2026

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe.

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe. It will be held on Monday 11-12th May …

Event details
Event - 27th April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Event details

Seven HGF Attorneys Recognised in the 2026 Pro Bono Recognition List

We’re proud to share that seven of our attorneys have been named on the 2026 Pro Bono Recognition List of England & Wales, recognising those who have dedicated 25 hours …

Read article

PRESS RELEASE - Oliver Pooley joins HGF as a Partner 21st April 2026

HGF is pleased to announce the appointment of Oliver Pooley who will be joining the firm as a Partner on 21st April 2026. Oliver joins our Technology & Engineering Group …

Read article